Regnante Keith

CFO

Latest Insider Transactions

1 transactions (past 365 days)

KROS
CFO
Sale
$77.5K
4,739 shares @ $16.35
Filed 2026-02-20Trade 2026-02-18
Keros Therapeutics, Inc.